The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBakkavor Regulatory News (BAKK)

Share Price Information for Bakkavor (BAKK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 121.00
Bid: 117.50
Ask: 120.00
Change: 1.50 (1.26%)
Spread: 2.50 (2.128%)
Open: 117.00
High: 121.00
Low: 117.00
Prev. Close: 119.50
BAKK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

23 May 2019 07:00

RNS Number : 9087Z
Bakkavor Group PLC
23 May 2019
 

 

23 May 2019

Bakkavor Group plc

Trading Update

 

Bakkavor Group plc ("Bakkavor" or "the Group"), the leading provider of fresh prepared food, will provide the following update on trading for the period from 30 December 2018 to date ("the period") at its Annual General Meeting today.

As we outlined at the 2018 full year results presentation, subdued consumer confidence and inflationary pressures continued into 2019. Trading since the year end has been in line with management expectations and our guidance for the full year remains unchanged, with Group performance broadly in line with 2018.

We continue to invest for the long-term and have further strengthened our position in the important desserts category through the recently announced acquisition of Blueberry Foods. In addition, as we maintain our focus on protecting margins, at the end of April we completed the closure of Freshcook, a loss-making site in the UK. Elsewhere across the Group, we continue to seek further opportunities to increase operating efficiencies and optimise capacity.

Demand is strong in our International markets; we are excited by the opportunities and continue to structure our businesses in the US and China for long-term growth.

Despite current UK market challenges, we remain confident that our strategy, combined with our scale and expertise, leaves us well placed to capitalise on future growth opportunities.

ENQUIRIES

Institutional investors and analysts:

Peter Gates, Chief Financial Officer

Sally Barrett-Jolley, Head of Corporate Affairs +44 (0) 20 7908 6143

Media:

Tulchan Communications +44 (0) 20 7353 4200

Catherine James, Will Smith, Jessica Reid

LEI number: 213800COL7AD54YU9949 

 

DISCLAIMER - FORWARD-LOOKING STATEMENTS 

This trading update, prepared by Bakkavor Group plc (the "Company"), may contain forward-looking statements about Bakkavor Group plc and its subsidiaries (the "Group"). Forward-looking statements involve uncertainties because they relate to events, and depend on circumstances, that will, or may, occur in the future. If the assumptions on which the Group bases its forward-looking statements change, actual results may differ from those expressed in such statements. Forward-looking statements speak only as of the date they are made and the Company undertakes no obligation to update these forward-looking statements. Nothing in this statement should be construed as a profit forecast.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTQLLFLKEFXBBB
Date   Source Headline
11th Apr 201910:50 amRNSDirector/PDMR Shareholding
8th Apr 20193:57 pmRNSFTSE 250 movers: Saga sinks, Indivior increases
8th Apr 20197:00 amRNSAnnual Financial Report
28th Feb 20194:41 pmRNSSecond Price Monitoring Extn
28th Feb 20194:35 pmRNSPrice Monitoring Extension
28th Feb 20197:00 amRNSFinal Results
27th Feb 20194:40 pmRNSSecond Price Monitoring Extn
27th Feb 20194:35 pmRNSPrice Monitoring Extension
18th Jan 20197:00 amRNSTrading Statement
13th Dec 20184:41 pmRNSSecond Price Monitoring Extn
13th Dec 20184:36 pmRNSPrice Monitoring Extension
12th Nov 20183:07 pmRNSDirector Declaration
26th Oct 20187:00 amRNSDirector/PDMR Shareholding
6th Sep 20187:00 amRNSHalf-year Report
6th Sep 20187:00 amRNSAcquisition
12th Jul 201811:11 amRNSDirectorate Change
23rd May 20183:55 pmRNSResult of AGM
23rd May 20187:00 amRNSTrading Statement
9th May 20184:40 pmRNSSecond Price Monitoring Extn
9th May 20184:35 pmRNSPrice Monitoring Extension
10th Apr 201812:08 pmRNSDirector/PDMR Shareholding
10th Apr 201811:37 amRNSAnnual Financial Report
3rd Apr 20187:00 amRNSDirectorate Change
28th Feb 20187:00 amRNSFinal Results
18th Jan 20187:00 amRNSStatement re Broker Appointment
18th Jan 20187:00 amRNSTrading Statement
8th Dec 20177:12 amRNSHolding(s) in Company
8th Dec 20177:11 amRNSHolding(s) in Company
8th Dec 20177:10 amRNSHolding(s) in Company
8th Dec 20177:00 amRNSHolding(s) in Company
21st Nov 20172:24 pmRNSHolding(s) in Company
20th Nov 20171:46 pmRNSDirector/PDMR Shareholding
16th Nov 20178:06 amRNSAdmission to Trading on the London Stock Exchange

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.